跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EMPAZOX 25 Empagliflozin Film Coated Tablets 25 mg - HSA Drug Approval Details
Approvals
/
HSA
/
EMPAZOX 25 Empagliflozin Film Coated Tablets 25 mg
Approved
THERAPEUTIC
EMPAZOX 25 Empagliflozin Film Coated Tablets 25 mg
Annora Pharma Private Limited (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
May 26, 2026
Approval ID
cbbae17ebe52172b
Company
Annora Pharma Private Limited (INDIA)
Type
Therapeutic
Approval Details
Approval Id
cbbae17ebe52172b
Drug Name
EMPAZOX 25 Empagliflozin Film Coated Tablets 25 mg
Product Name
EMPAZOX 25 Empagliflozin Film Coated Tablets 25 mg
Approval Number
SIN17547P
Approval Date
2026-05-26
Registrant
HETERO SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 26, 2026
Approval ID
cbbae17ebe52172b
Type
Therapeutic
Back to HSA Approvals
